Logo
A

Asceneuron SA

17 employees

Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.

Basic info

Industry

biotechnology research

Sectors

Neurodegeneration
Biotechnology
Therapeutics
Parkinson's disease
Small Molecule Drug Discovery
Tauopathies
Orphan Diseases
Health Care
Alzheimer's disease
PSP
Novel Therapeutics

Date founded

2012

Funding rounds raised

Total raised

$31M

from 3 investors over 3 rounds

A

Asceneuron SA raised $31M on September 29, 2015

Investors: Sofinnova Partners, S.R. One Ltd and M Ventures

FAQ